Bruce Bryan brings 25 years of experience in the pharmaceutical and biotechnology industry across Manufacturing, CMC, Project Management and Operations. Bruce has held positions at Genentech, Elan Pharmaceuticals, InterMune, Napo Pharmaceuticals, Alios Biopharma, and Janssen Pharmaceuticals. While at Alios Biopharma, he held multiple roles within the leadership team, helping secure capital and grow the company over 7 years leading to an acquisition by Janssen Pharmaceuticals for $1.75 Billion USD. During his time at Janssen, he helped identify a new site location and was on a core team responsible for building a state-of-the-art 298,000 SF R&D facility to expand presence and capabilities in the San Francisco Bay Area.
Bruce holds a Bachelor of Science Degree in Biological Sciences from California State Polytechnic University, San Luis Obispo, California, and an MBA from University of Atlanta.